Search

everythinglearnresearchcommunity

for

Search:↓

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

Hesperidin protects rat testicles from finasteride damage and improves sperm health.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Using single dermal papillae is unreliable for analyzing androgen metabolism in hair follicles.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Eurycoma longifolia extract may help increase testosterone levels and reduce andropause symptoms.

Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.

A 36-year-old person with a female appearance but male chromosomes was diagnosed with a rare enzyme deficiency affecting sexual development.

The combination of arginine and zinc reduces hair loss and increases hair growth effectively.

5ARI treatment improves hair growth in older men with minimal side effects.

Baicalin may effectively treat hair loss by inhibiting 5α-reductase.

Finasteride and dutasteride do not significantly change beard thickness in men.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Betula platyphylla extract, particularly the H3-2 fraction, may help treat hair loss by promoting cell growth and inhibiting a hair loss-related enzyme.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.